Role of Molecular Imaging in AD and Dementia

To provide up-to-date information to primary care physicians, neurologists, psychiatrists and geriatricians about the clinical utility and availability molecular neuroimaging studies in the evaluation of patients with suspected dementia, we would like to hold an evening symposium at the University of Pennsylvania (UPenn) and collaborate with the UPenn departments of Radiology, Neurology and Psychiatry  to ensure that the program represents the perspectives of imaging specialists and referring physicians. This event will offer free CME for participants over dinner and will capture learning metrics via an audience response system. 
Register Now

Date: Wednesday, September 16, 2015

Location: University of Pennsylvania, Philadelphia, PA

Learning Objectives:

  1. Recognize classic imaging features of neurodegenerative diseases resulting in memory loss with a focus on Alzheimer’s.
  2. Explain the mechanisms of FDG-PET and amyloid-PET imaging.
  3. Discuss the differences between MRI and PET.
  4. Identify the appropriate indications and limitations of these imaging studies using case examples.


5:30 – 6:00

Refreshments/Dinner Buffet

6:00 – 6:25

Clinical Diagnosis and Care of Dementia (20 min) and Q&A (5 min), Given by Geriatric Psychiatrist/Clinical Memory Specialist

6:25 – 6:50

 FDG-PET, Amyloid-PET and MRI: What the Ordering Physician Needs to Know (20 min) and Q&A (5 min),  Given by Clinical Imager

6:50 – 7:15

Case Studies Illustrating  Appropriate Use of Brain Imaging :  Identifying the Right Patient for the Scan  (20 min) and Q&A (5 min), given by either geriatrician or internist to present cases

7:15 – 7:45

Panel Discussion (30 min)